Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
06/1995
06/22/1995WO1995016675A1 Benzo-fused lactams promote release of growth hormone
06/22/1995WO1995016674A1 Aminosulphonyl-phenyl-1h-pyrrole derivatives, method of their preparation and their use
06/22/1995WO1995016672A1 Vitamin d amine and amide derivatives
06/22/1995WO1995016671A1 Triflate-mediated preparation and use of iodonium compounds
06/22/1995WO1995016663A1 N,n'-bis(2-hydroxybenzyl)ethylenediamine-n,n'-diacetic acid derivatives as chelating agents
06/22/1995WO1995016661A1 Salts of a polyunsaturated fatty acid and pharmaceutical formulations containing them
06/22/1995WO1995016659A1 Novel retinoid conjugate compounds and methods for treating skin aging
06/22/1995WO1995016511A1 Deep-bed filter for exterminating micro-organisms and inactivating viruses and its use
06/22/1995WO1995016466A1 Antisense oligonucleotides to suppress eicosanoid formation
06/22/1995WO1995016452A2 Use of macrophage depleting agents for prolonging the survival of non-autologus hematopoietic cell transplants and animal model assay systems
06/22/1995WO1995016451A1 Tablets for the controlled release of 4-asa
06/22/1995WO1995016450A1 Use of pentoxifyllin in the treatment of multiple sclerosis
06/22/1995WO1995016449A1 6-(2-imidazolinylamino)quinoxaline compounds useful as alpha-2 adrenoceptor agonists
06/22/1995WO1995016448A1 Paroxetine tablets and process to prepare them
06/22/1995WO1995016447A1 Anthelmintic composition containing rafoxanide and fenbendazole
06/22/1995WO1995016446A1 Ranitidine compositions
06/22/1995WO1995016445A1 Pharmaceutical compositions for topical use containing (s)-2-(4-isobutylphenyl)propionic acid
06/22/1995WO1995016444A1 Composition and method for producing local anesthesia of the skin
06/22/1995WO1995016443A1 Di-tert-butylphenol compounds useful as anti-inflammatory agents
06/22/1995WO1995016442A1 Novel potassium channel agonist produced from trichoderma virens
06/22/1995WO1995016441A1 Ultramicroemulsions from spontaneously dispersible concentrates with pharmacologically effective esters of apocarotinols
06/22/1995WO1995016435A2 Improved intraocular irrigating solution containing non-steroidal antiinflammatory agent
06/22/1995WO1995016434A1 Sucrose ester c-20 to c-28 alcohol formulations
06/22/1995WO1995016359A1 Growth promoting composition for fish
06/22/1995WO1995016353A1 Systemic gene treatment of connective tissue diseases
06/22/1995WO1995015381A3 Human mutator gene hmsh2 and hereditary non polyposis colorectal cancer
06/22/1995WO1995013380A3 Method and reagent for treatment of arthritic conditions
06/22/1995WO1995011048A3 METHODS AND COMPOSITIONS OF A BIOARTIFICIAL KIDNEY SUITABLE FOR USE IN VIVO OR $i(EX VIVO)
06/22/1995WO1995010271A3 Phenylacetate and derivatives alone or in combination with other compounds against neoplastic conditions and other disorders
06/22/1995WO1995003407A3 Oligonucleotides with activity against human immunodeficiency virus
06/22/1995DE4444606A1 Sennoside A and B prodn.
06/22/1995DE4407742C1 Transdermal patch for treating tumours
06/22/1995DE4406332C1 Use of transdermal glyceryl tri:nitrate formulations in pregnancy
06/22/1995DE4343647A1 Use of alpha-lipoic acid and its enantiomers
06/22/1995DE4343600A1 Use of new and known phosphate ester(s)
06/22/1995DE4343599A1 Use of new and known pyrimidyl phosphonate ester and thio-ester cpds.
06/22/1995DE4343592A1 Use of lipoic acid cpds. for prodn. of CNS medicaments
06/22/1995DE4342560A1 Use of 1,4,5,6-tetra:hydro-4-pyrimidine carboxylic acid derivs. in cosmetics
06/22/1995DE4334936C1 Medicament for treating hypertension
06/22/1995CA2274387A1 Paroxetine tablets and process to prepare them
06/22/1995CA2179203A1 N,n'-bis(2-hydroxybenzyl)ethylenediamine-n,n'-diacetic acid derivatives as chelating agents
06/22/1995CA2179179A1 3-substituted 1-arylindole compounds
06/22/1995CA2179168A1 Antisense oligonucleotides to suppress eicosanoid formation
06/22/1995CA2179147A1 Improved intraocular irrigating solution containing non-steroidal antiinflammatory agent
06/22/1995CA2179068A1 Novel potassium channel agonist produced from trichoderma virens
06/22/1995CA2179009A1 Di-tert-butylphenol compounds useful as anti-inflammatory agents
06/22/1995CA2179006A1 6-(2-imidazolinylamino)quinoxaline compounds useful as alpha-2 adrenoceptor agonists
06/22/1995CA2178964A1 Novel retinoid conjugate compounds and methods for treating skin aging
06/22/1995CA2178090A1 Vitamin d amine and amide derivatives
06/22/1995CA2176848A1 Use of pentoxifyllin in the treatment of multiple sclerosis
06/22/1995CA2176247A1 Platelet activating factor antagonists: imidazopyridine indoles
06/22/1995CA2176040A1 Improved process for the synthesis of 2-amino-3,5-dihydro-7-substituted-4h-pyrrolo[3,2-d]pyrimidin-4-ones
06/22/1995CA2176036A1 Cyclic amide derivatives as neurokinin a antagonists
06/22/1995CA2174729A1 A method of preventing depletion of non-autologous hematopoietic cells and animal model systems for use thereof
06/22/1995CA2155929A1 Systemic gene treatment of connective tissue diseases
06/22/1995CA2154890A1 3'-aziridino-anthracycline derivatives
06/22/1995CA2138638A1 Branched-amino-substituted thiazoles, processes for their preparation and the pharmaceutical compositions which contain them
06/22/1995CA2138513A1 Methods of inhibiting myeloperoxidase activity
06/22/1995CA2138511A1 Methods of inhibiting atrophy of the skin and vagina
06/22/1995CA2138510A1 Methods of inhibiting dysfunctional uterine bleeding
06/22/1995CA2138509A1 Methods of inhibiting autoimmune diseases
06/22/1995CA2138508A1 Methods for inhibiting ldl oxidation and atherosclerosis
06/22/1995CA2138507A1 Methods of inhibiting sexual precocity
06/22/1995CA2138506A1 Methods of inhibiting male infertility
06/22/1995CA2138505A1 Methods of inhibiting the symptoms of premenstrual syndrome/late luteal phase dysphoric disorder
06/22/1995CA2138501A1 Methods of inhibiting breast disorders
06/22/1995CA2138500A1 Methods of inhibiting ovarian dysgenesis, delayed puberty, or sexual infantilism
06/22/1995CA2138499A1 Methods for inhibiting vasomotor symptoms and attending psychological disturbances surrounding post-menopausal syndrome
06/22/1995CA2138498A1 Methods of inhibiting hirsutism and alopecia in women
06/22/1995CA2138497A1 Method for increasing libido in post-menopausal women
06/22/1995CA2138496A1 Methods of inhibiting pulmonary hypertensive diseases
06/22/1995CA2138495A1 Methods of inhibiting alzheimer's disease
06/22/1995CA2138494A1 Methods of inhibiting turner's syndrome
06/22/1995CA2138493A1 Methods of inhibiting thrombin
06/22/1995CA2138492A1 Methods of increasing macrophage function
06/22/1995CA2138491A1 Methods of inhibiting seborrhea and acne
06/22/1995CA2138490A1 Methods of increasing thrombomodulin expression
06/22/1995CA2138459A1 Methods of inhibiting cns problems in post-menopausal women
06/22/1995CA2138458A1 Methods of inhibiting obsessive-compulsive and consumptive disorders
06/22/1995CA2138457A1 Non-peptide tachykinin receptor antagonists
06/22/1995CA2138456A1 Methods of inhibiting fertility in women
06/22/1995CA2138455A1 Methods for inhibiting weight gain or inducing weight loss
06/22/1995CA2138454A1 Methods of inhibiting imperfect tissue repair
06/22/1995CA2138421A1 Use of benzo [g] quinolines
06/22/1995CA2138331A1 Use of phosphoric acid esters and phosphonic acid esters for treating disorders of cognitive function and depressions
06/22/1995CA2138100A1 Methods of treating menstrual symptoms and compositions therefor
06/22/1995CA2135979A1 Biaryl phospholipase a2 inhibitors
06/21/1995EP0658585A2 Aminophenylalanine derivatives, process for their production, their use and agents containing them as anti-coagulants
06/21/1995EP0658559A1 Thienothiazin derivatives, process for their preparation and their use as 5-dipoxygenase and cyclooxygenase inhibitors
06/21/1995EP0658558A1 Separation of cephalosporin isomers
06/21/1995EP0658557A1 Eburnane derivatives, processes for their preparation and pharmaceutical compositions containing them
06/21/1995EP0658554A1 N-benzyl dihydroindole LTD4 antagonists
06/21/1995EP0658553A1 Polycyclic aromatic compounds, pharmaceutical compositions containing them and uses thereof
06/21/1995EP0658552A1 Process for the preparation of alpha-tocopherol derivatives
06/21/1995EP0658551A1 Cyclic depsipeptides having 18 ringatoms and their use in controlling endoparasites
06/21/1995EP0658550A2 Amino acid salts of and methods for preparing antihypercholesterolemic tetrazole compounds
06/21/1995EP0658546A1 Novel 3-pyrazolecarboxamide derivatives with cannabinoid receptor affinity
06/21/1995EP0658545A1 Decahydro-isoquinoline derivatives
06/21/1995EP0658539A1 Excitatory amino acid receptor antagonists
06/21/1995EP0658538A1 Diagnosis, evaluation and treatment of coronary artery disease by exercise simulation using closed loop drug delivery of an exercise simulating agent beta agonist
1 ... 7008 7009 7010 7011 7012 7013 7014 7015 7016 7017 7018 7019 7020 7021 7022 7023 7024 7025 7026 7027 7028 ... 7860